- Active not recruitingPHASE3
A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy
This study looks at two different daily pill combinations for adults newly diagnosed with HIV. It compares a two-drug treatment with a three-drug treatment to see which is safer and works better for controlling the virus.
For: HIV · HIV InfectionsArgentina · Belgium · Denmark - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2b, Randomized, Active-Controlled, Double-Blind, Dose-Ranging Clinical Study to Evaluate a Switch to Islatravir (ISL) and MK-8507 Once-Weekly in Adults with HIV-1 Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) Once-Daily
This study is testing a new weekly pill for adults with HIV-1, who are already doing well on their current daily medication. It aims to see how safe and effective a switch to the new treatment is.
For: HIV-1 InfectionFrance - Ongoing, recruitingTherapeutic confirmatory (Phase III)
The Italian Cohort (ITACO) and the Analytical Antiretroviral Treatment Interruption Italian Cohort (ITACO-ATI) study guided by molecular HIV-1 reservoir profiling
This study looks at HIV in people who got it at birth. It's trying to find new ways to understand how the virus hides in the body and if some people can safely stop their HIV medicine under close medical watch.
For: perinatally HIV infectionItaly